Q4 2013 Teva Pharmaceuticals Earnings Conference call (Webcast)

Feb. 6.14 | About: Teva Pharmaceutical (TEVA)

Teva Pharmaceutical Industries Limited (TEVA): Q4 EPS of $1.42 beats by $0.02. Revenue of $5.45B (+4.8% Y/Y) beats by $430M.

The following audio is from a conference call that will begin on February 06, 2014 at 08:00 AM ET. The audio will stream live while the call is active, and can be replayed upon its completion.

If you would like to view a transcript of this call, please click here.